Bionano Genomics, Inc. SEC filings BNGO

Bionano Genomics, Inc. has 629 filings in SEC EDGAR's recent list, going back to Aug 31, 2007. Its latest annual report, Form ARS, was filed on Apr 2, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 10, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Sep 14, 2026 (regulation fd disclosure). The company's fiscal year ends on December 31.

Bionano Genomics, Inc. SEC filings
Form Description Filed Period
424B3 Prospectus Nov 5, 2026 —
424B3 Prospectus Nov 5, 2026 —
S-3/A Filing Nov 2, 2026 —
S-1 Registration statement Oct 27, 2026 —
8-K Current report
Regulation FD disclosure
Sep 14, 2026 Sep 14, 2026
10-Q Quarterly report Aug 10, 2026 Jun 30, 2026
8-K Current report
Results of operations
Aug 10, 2026 Aug 10, 2026
8-K Current report
Other events
Jun 24, 2026 Jun 24, 2026
8-K Current report
Officer or director change
Jun 5, 2026 Jun 2, 2026
8-K Current report
Other events
May 28, 2026 May 28, 2026
8-K Current report
Shareholder vote results
May 14, 2026 May 14, 2026
10-Q Quarterly report May 13, 2026 Mar 31, 2026
8-K Current report
Results of operations
May 13, 2026 May 13, 2026
S-3 Shelf registration May 8, 2026 —
8-K Current report
Officer or director change, Other events
May 6, 2026 May 5, 2026
ARS Annual report to shareholders Apr 2, 2026 Dec 31, 2025
DEFA14A Additional proxy material Apr 2, 2026 —
DEF 14A Proxy statement Apr 2, 2026 Apr 1, 2026
S-8 Employee stock plan registration Mar 25, 2026 —
10-K Annual report Mar 23, 2026 Dec 31, 2025
8-K Current report
Results of operations
Mar 23, 2026 Mar 23, 2026
8-K Current report
Results of operations
Jan 12, 2026 Jan 12, 2026
10-Q Quarterly report Nov 13, 2025 Sep 30, 2025
8-K Current report
Results of operations
Nov 13, 2025 Nov 13, 2025
424B5 Prospectus supplement Oct 17, 2025 —
8-K Current report
Material agreement, Other events
Sep 18, 2025 Sep 16, 2025
EFFECT Filing Sep 16, 2025 —
424B4 Prospectus Sep 16, 2025 —
CORRESP Letter to the SEC Sep 11, 2025 —
CORRESP Letter to the SEC Sep 11, 2025 —
S-1 Registration statement Sep 11, 2025 —
10-Q Quarterly report Aug 14, 2025 Jun 30, 2025
8-K Current report
Results of operations
Aug 14, 2025 Aug 14, 2025
UPLOAD Letter from the SEC Aug 1, 2025 —
DRS Filing Jul 30, 2025 —
8-K/A Amended current report
Shareholder vote results
Jun 18, 2025 Jun 10, 2025
8-K Current report
Officer or director change, Shareholder vote results
Jun 13, 2025 Jun 10, 2025
10-Q Quarterly report May 14, 2025 Mar 31, 2025
8-K Current report
Results of operations
May 14, 2025 May 14, 2025
ARS Annual report to shareholders Apr 28, 2025 Dec 31, 2024
DEFA14A Additional proxy material Apr 28, 2025 —
DEF 14A Proxy statement Apr 28, 2025 Jun 11, 2025
PRE 14A Preliminary proxy statement Apr 18, 2025 Jun 11, 2025
424B5 Prospectus supplement Apr 2, 2025 —
S-8 Employee stock plan registration Apr 2, 2025 —
10-K Annual report Mar 31, 2025 Dec 31, 2024
8-K Current report
Results of operations
Mar 31, 2025 Mar 31, 2025
8-K Current report
Material agreement
Feb 21, 2025 Feb 21, 2025
424B5 Prospectus supplement Feb 21, 2025 —
8-K Current report
Agreement ended
Feb 10, 2025 Feb 4, 2025
8-K Current report
Change to shareholder rights, Bylaw or fiscal year change, Regulation FD disclosure
Jan 27, 2025 Jan 24, 2025
8-K Current report
Shareholder vote results
Jan 16, 2025 Jan 15, 2025
424B3 Prospectus Jan 14, 2025 —
8-K Current report
Results of operations
Jan 13, 2025 Jan 13, 2025
EFFECT Filing Jan 10, 2025 —
CORRESP Letter to the SEC Jan 8, 2025 —
S-3/A Filing Jan 8, 2025 —
UPLOAD Letter from the SEC Jan 8, 2025 —
8-K Current report
Material agreement, Regulation FD disclosure, Other events
Jan 6, 2025 Jan 3, 2025
424B5 Prospectus supplement Jan 6, 2025 —
S-3 Shelf registration Jan 3, 2025 —
8-K Current report
Material agreement, Unregistered share sale, Regulation FD disclosure
Jan 3, 2025 Dec 31, 2024
DEFA14A Additional proxy material Dec 19, 2024 —
DEFA14A Additional proxy material Dec 5, 2024 —
DEF 14A Proxy statement Dec 5, 2024 Jan 15, 2025
8-K Current report
Shareholder vote results
Dec 2, 2024 Nov 27, 2024
PRE 14A Preliminary proxy statement Nov 25, 2024 Jan 15, 2025
10-Q Quarterly report Nov 14, 2024 Sep 30, 2024
8-K Current report
Results of operations
Nov 13, 2024 Nov 13, 2024
8-K Current report
Material agreement, Regulation FD disclosure, Other events
Oct 31, 2024 Oct 30, 2024
424B5 Prospectus supplement Oct 31, 2024 —
DEFA14A Additional proxy material Oct 31, 2024 —
8-K Current report
Results of operations
Oct 10, 2024 Oct 10, 2024
DEFA14A Additional proxy material Oct 3, 2024 —
8-K Current report
Exit or restructuring costs, Officer or director change, Regulation FD disclosure
Sep 9, 2024 Sep 4, 2024
DEFA14A Additional proxy material Aug 21, 2024 —
DEF 14A Proxy statement Aug 21, 2024 Oct 2, 2024
EFFECT Filing Aug 12, 2024 —
424B3 Prospectus Aug 12, 2024 —
PRE 14A Preliminary proxy statement Aug 9, 2024 Oct 2, 2024
CORRESP Letter to the SEC Aug 8, 2024 —
UPLOAD Letter from the SEC Aug 7, 2024 —
10-Q Quarterly report Aug 7, 2024 Jun 30, 2024
8-K Current report
Results of operations
Aug 7, 2024 Aug 7, 2024
S-3 Shelf registration Jul 31, 2024 —
8-K Current report
Listing notice
Jul 18, 2024 Jul 12, 2024
D Filing Jul 10, 2024 —
8-K Current report
Material agreement, Unregistered share sale, Regulation FD disclosure, Other events
Jul 8, 2024 Jul 4, 2024
424B5 Prospectus supplement Jul 8, 2024 —
8-K Current report
Shareholder vote results
Jun 21, 2024 Jun 18, 2024
EFFECT Filing Jun 20, 2024 —
424B3 Prospectus Jun 20, 2024 —
CORRESP Letter to the SEC Jun 17, 2024 —
UPLOAD Letter from the SEC Jun 14, 2024 —
S-3 Shelf registration Jun 10, 2024 —
D Filing Jun 5, 2024 —
8-K Current report
Material agreement, Agreement ended, New debt, Unregistered share sale, Regulation FD disclosure, Other events
May 28, 2024 May 23, 2024
S-8 Employee stock plan registration May 8, 2024 —
10-Q Quarterly report May 8, 2024 Mar 31, 2024
8-K Current report
Results of operations, Exit or restructuring costs
May 8, 2024 May 8, 2024
DEFA14A Additional proxy material Apr 26, 2024 —
DEF 14A Proxy statement Apr 26, 2024 Jun 18, 2024
8-K Current report
Other events
Apr 8, 2024 Apr 8, 2024
424B5 Prospectus supplement Apr 8, 2024 —
8-K Current report
Material agreement, Regulation FD disclosure
Apr 5, 2024 Apr 4, 2024
ARS Annual report to shareholders Mar 6, 2024 Dec 31, 2023
10-K Annual report Mar 5, 2024 Dec 31, 2023
8-K Current report
Results of operations, Exit or restructuring costs
Mar 5, 2024 Mar 1, 2024
8-K Current report
Material agreement, Regulation FD disclosure
Feb 28, 2024 Feb 27, 2024
8-K Current report
Results of operations
Jan 8, 2024 Jan 8, 2024
8-K Current report Nov 24, 2023 Nov 24, 2023
424B3 Prospectus Nov 8, 2023 —
10-Q Quarterly report Nov 8, 2023 Sep 30, 2023
8-K Current report
Results of operations, Regulation FD disclosure
Nov 8, 2023 Nov 8, 2023
EFFECT Filing Nov 6, 2023 —
CORRESP Letter to the SEC Nov 2, 2023 —
UPLOAD Letter from the SEC Nov 2, 2023 —
D Filing Oct 27, 2023 —
S-3 Shelf registration Oct 26, 2023 —
8-K Current report
Material agreement, Results of operations, New debt, Exit or restructuring costs, Unregistered share sale, Regulation FD disclosure
Oct 11, 2023 Oct 9, 2023
424B5 Prospectus supplement Oct 11, 2023 —
25-NSE Delisting notice Aug 17, 2023 —
8-K Current report
Officer or director change, Regulation FD disclosure
Aug 14, 2023 Aug 11, 2023
10-Q Quarterly report Aug 9, 2023 Jun 30, 2023
8-K Current report
Results of operations
Aug 9, 2023 Aug 9, 2023
8-K Current report
Change to shareholder rights, Bylaw or fiscal year change
Aug 4, 2023 Aug 4, 2023
8-K Current report Jul 19, 2023 Jul 18, 2023
8-K Current report
Shareholder vote results
Jun 16, 2023 Jun 14, 2023
8-K Current report
Listing notice
Jun 2, 2023 May 30, 2023
EFFECT Filing May 10, 2023 —
10-Q Quarterly report May 9, 2023 Mar 31, 2023
8-K Current report
Results of operations
May 9, 2023 May 9, 2023
CORRESP Letter to the SEC May 8, 2023 —
S-3/A Filing May 8, 2023 —
DEFA14A Additional proxy material May 1, 2023 —
DEFA14A Additional proxy material Apr 28, 2023 —
DEF 14A Proxy statement Apr 28, 2023 Jun 14, 2023
ARS Annual report to shareholders Apr 28, 2023 Dec 31, 2022
8-K Current report
Results of operations
Apr 24, 2023 Apr 24, 2023
PRE 14A Preliminary proxy statement Apr 14, 2023 Jun 14, 2023
8-K Current report
Material agreement, Unregistered share sale, Change to shareholder rights, Bylaw or fiscal year change
Apr 14, 2023 Apr 13, 2023
UPLOAD Letter from the SEC Mar 17, 2023 —
8-K Current report
Other events
Mar 13, 2023 Mar 13, 2023
S-3 Shelf registration Mar 10, 2023 —
S-8 Employee stock plan registration Mar 9, 2023 —
10-K Annual report Mar 9, 2023 Dec 31, 2022
8-K Current report
Results of operations
Mar 9, 2023 Mar 9, 2023
POSASR Filing Mar 9, 2023 —
8-K Current report
Results of operations, Other events
Feb 3, 2023 Feb 2, 2023
8-K Current report
Results of operations
Jan 5, 2023 Jan 5, 2023
8-K Current report
Acquisition or sale of assets
Nov 30, 2022 Nov 30, 2022
8-K Current report
Other events
Nov 29, 2022 Nov 29, 2022
8-K Current report
Material agreement, Regulation FD disclosure, Other events
Nov 28, 2022 Nov 23, 2022
8-K Current report
Officer or director change
Nov 18, 2022 Nov 14, 2022
CT ORDER Filing Nov 18, 2022 —
10-Q Quarterly report Nov 3, 2022 Sep 30, 2022
8-K Current report
Results of operations
Nov 3, 2022 Nov 3, 2022
10-Q Quarterly report Aug 4, 2022 Jun 30, 2022
8-K Current report
Results of operations
Aug 4, 2022 Aug 4, 2022
UPLOAD Letter from the SEC Jul 29, 2022 —
CORRESP Letter to the SEC Jul 18, 2022 —
CORRESP Letter to the SEC Jul 8, 2022 —
CT ORDER Filing Jul 5, 2022 —
UPLOAD Letter from the SEC Jun 23, 2022 —
8-K Current report
Shareholder vote results
Jun 10, 2022 Jun 9, 2022
DEFA14A Additional proxy material May 27, 2022 —
10-Q Quarterly report May 5, 2022 Mar 31, 2022
8-K Current report
Results of operations
May 5, 2022 May 5, 2022
DEFA14A Additional proxy material Apr 27, 2022 —
DEF 14A Proxy statement Apr 27, 2022 Jun 9, 2022
S-8 Employee stock plan registration Mar 1, 2022 —
10-K Annual report Mar 1, 2022 Dec 31, 2021
8-K Current report
Results of operations
Mar 1, 2022 Mar 1, 2022
8-K Current report
Officer or director change
Feb 23, 2022 Feb 17, 2022
8-K Current report
Results of operations
Jan 12, 2022 Jan 12, 2022
8-K Current report
Material agreement
Dec 30, 2021 Dec 30, 2021
8-K Current report
Officer or director change
Dec 23, 2021 Dec 21, 2021
S-8 Employee stock plan registration Nov 4, 2021 —
10-Q Quarterly report Nov 4, 2021 Sep 30, 2021
8-K Current report
Results of operations, Other events
Nov 4, 2021 Nov 4, 2021
D Filing Oct 25, 2021 —
8-K Current report
Acquisition or sale of assets
Oct 19, 2021 Oct 18, 2021
8-K Current report
Material agreement, Unregistered share sale, Regulation FD disclosure, Other events
Oct 12, 2021 Oct 8, 2021
10-Q Quarterly report Aug 4, 2021 Jun 30, 2021
8-K Current report
Results of operations, Other events
Aug 4, 2021 Aug 4, 2021
8-K Current report
Shareholder vote results
Jun 11, 2021 Jun 10, 2021
8-K Current report
Agreement ended
May 14, 2021 May 14, 2021
10-Q Quarterly report May 13, 2021 Mar 31, 2021
8-K Current report
Results of operations, Other events
May 13, 2021 May 13, 2021
CT ORDER Filing May 4, 2021 —
DEFA14A Additional proxy material Apr 27, 2021 —
DEF 14A Proxy statement Apr 27, 2021 Jun 10, 2021
S-8 Employee stock plan registration Mar 24, 2021 —
8-K Current report
Other events
Mar 24, 2021 Mar 23, 2021
424B5 Prospectus supplement Mar 24, 2021 —
10-K Annual report Mar 23, 2021 Dec 31, 2020
8-K Current report
Results of operations, Other events
Mar 23, 2021 Mar 23, 2021
8-K Current report
Material agreement
Feb 19, 2021 Feb 15, 2021
8-K Current report
Other events
Jan 21, 2021 Jan 20, 2021
424B5 Prospectus supplement Jan 21, 2021 —

Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Laboratory Analytical Instruments (SIC 3826)
Listed as
BNGO (Nasdaq)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
San Diego, CA
SEC filer status
Non-accelerated filer, Smaller reporting company
SEC CIK
1411690
Former names
BioNano Genomics, Inc (until Oct 20, 2021); Bionano Genomics, Inc (until Oct 20, 2021); BioNanomatrix Inc (until Mar 24, 2011)

Other Laboratory Analytical Instruments companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.